Home UK

The risk of coronary artery by lowering the first dose of AstraZeneca and Pfizer vaccines


A study in the United Kingdom found that the risk of developing covidosis decreased rapidly after taking the first dose of the AstraZeneca or Pfizer vaccine. The media reported on the BBC.

Research by The Office for National Statistics (ONS) and the University of Oxford says that the AstraZeneca or Pfizer vaccine works in the same way for all people over the age of 65. These vaccines have worked just as well in people with underlying health problems.

Studies have also shown that strong antibody reactions are developed in people of all ages after taking two doses of the vaccine. And after being vaccinated against Astrageneca or Pfizer, there has been some positive response from everyone.

The study was based on coronary examinations of 370,000 people in the United Kingdom. This is by far the largest study in terms of numbers. However, the study has not yet been reviewed by other researchers or published in any journal. The effects of the corona vaccine on antibody production and disease resistance were two aspects of this study.

One study found that taking the first dose of the Oxford-Astrageneca or Pfizer-Bioentech vaccine reduced the risk of corona infection by 75 percent.

Those who were vaccinated between December last year and early April this year saw a 74 percent reduction in coronary heart disease, including symptoms, three weeks after vaccination. And asymptomatic corona infections decreased by 56 percent.

And those who took the second dose of Pfizer’s coronary vaccine had a 90 percent reduced risk of infection. However, it was not possible to give the same account in the case of AstraZeneca vaccine. Because of the late start of the AstraZeneca vaccination program, very few people have been able to take a second dose of this vaccine.

In addition, studies have shown that two vaccines are effective against the Kent variant of the coronavirus (B118).

Two studies have been conducted on the basis of survey data from the novel Coronavirus Infection. The survey was jointly conducted by Oxford University, ONS and the Department for Health and Social Care.


Please enter your comment!
Please enter your name here